Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3352-3356

  Corn, Paul G ^a   Kuerbitz, Steven J ^c,d   Van Noesel, Max M ^b   Esteller, Manel ^a   Compitello, Nicole ^c   Baylin, Stephen B ^a   Herman, James G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; AUTORADIOGRAPHY; BURKITT LYMPHOMA; CELL CULTURE; CELL CYCLE; DISEASE ASSOCIATION; EXON; GENE LOCATION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; BURKITT LYMPHOMA; CHILD; CHROMOSOMES, HUMAN, PAIR 1; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033565514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
2. Zhu, J., Jiang, J., Zhou, W., and Chen, X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res., 58: 5061-5065, 1998.
3. Schwab, M., Praml, C., and Amler, L. C. Genomic instability in 1p and human malignancies. Genes Chromosomes & Cancer, 16: 211-229, 1996.
4. Kovalev, S., Marchenko, N., Swendeman, S., LaQuaglia, M., and Moll, U. M. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ., 9: 897-903, 1998.
5. Mai, M., Huang, H., Reed, C., Qian, C., Smith, J. S., Alderete, B., Jenkins, R., Smith, D. I., and Liu, W. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions. Genomics, 51: 359-363, 1998.
6. Sunahara, M., Ichimiya, S., Nimura, Y., Takada, N., Sakiyama, S., Sato, Y., Todo, S., Adachi, W., Amano, J., and Nakagawara, A. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int. J. Oncol., 13: 319-323, 1998.
7. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., and Takahashi, T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58: 1380-1383, 1998.
8. Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S., and Nakagawara, A. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58: 2076-2077, 1998.
9. Mai, M., Qian, C., Yokomizo, A., Tindall, D. J., Bostwick, D., Polychronakos, C., Smith, D. I., and Liu, W. Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene, 17: 1739-1741, 1998.
10. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
11. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res., 59: 793-797, 1999.
12. Bachman, K. E., Herman, J. G., Corn, P. G., Merlo, A., Costello, J. F., Cavenee, W. K., Baylin, S. B., and Graff, J. R. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res., 59: 798-802, 1999.
13. Kass, S. U., Pruss, D., and Wolffe, A. P. How does DNA methylation repress transcription? Trends. Genet., 13: 444-449, 1997.
14. INK4A characterize the major types of hematological malignancies. Cancer Res., 57: 837-841, 1997.
15. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
16. Kuerbitz, S. J., and Baylin, S. B. Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase. Cell Growth Differ., 7: 847-853, 1996.
17. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P. J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/P16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Career Research, 55: 4525-4530, 1995.
18. Wong, H., Anderson, W. D., Cheng, T., and Riabowol, K. T. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal. Biochem., 223: 251-258, 1994.
19. Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y. M., and Nakagawara, A. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer, 78: 437-440, 1998.
20. Voeller, H. J., Truica, C. I., and Gelmann, E. P. β-catenin mutations in human prostate cancer. Cancer Res., 58: 2520-2523, 1998.
21. Bartolomei, M. S., Webber, A. L., Brunkow, M. E., and Tilghman, S. M. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev., 7: 1663-1673, 1993.
22. 6-methylguanine-DNA methyltransferase gene. Cancer Res., 57: 3672-3677, 1997.
23. Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., and Herman, J. G. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene, 17: 2413-2417, 1998.
24. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
25. Wada, M., Bartram, C. R., Nakamura, H., Hachiya, M., Chen, D. L., Borenstein, J., Miller, C. W., Ludwig, L., Hansen-Hagge, T. E., and Ludwig, W. D. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood, 82: 3163-3169, 1993.
26. Preudhomme, C., Dervite, I., Wattel, E., Vanrumbeke, M., Flactif, M., Lai, J. L., Hecquet, B., Coppin, M. C., Nelken, B., and Gosselin, B. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J. Clin. Oncol., 13; 812-820, 1995.
27. Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., and Dalla-Favera, R. p53 mutations in human lymphoid malignancies: association with Burkitt's lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 88: 5413-5417, 1991.
28. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., and Fenaux, P. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84: 3148-3157, 1994.
29. Koduru, P. R., Raju, K., Vadmal, V., Menezes, G., Shah, S., Susin, M., Kolitz, J., and Broome, J. D. Correlation between mutation in p53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood, 90: 4078-4091, 1997.